FINWIRES · TerminalLIVE
FINWIRES

UBSは、カナダ銀行は来週は横ばいとなるものの、対応準備はできていると見ている。

-- UBSは、カナダ銀行が来週水曜日の4月会合および年内を通して金利を据え置くと予想している。これは、今後の見通しに不確実性があるためだ。 同行は顧客向けレポートの中で、貿易摩擦や人工知能(AI)による混乱といったリスクは依然として存在し、中東情勢の緊張の見通しについても不確実性が残っていると指摘している。 UBSによると、最新のカナダの経済指標は「まちまち」だった。3月の総合インフレ率はエネルギー価格の上昇によって押し上げられた一方、コアインフレ率は鈍化し、労働市場は依然として低迷している。カナダ銀行の最新の調査では短期的なインフレ期待がわずかに上昇したが、同行は長期的なインフレ期待が比較的安定していることから、4月会合における金利見通しには依然として選択肢が残されていると予測している。 UBSは、カナダ銀行は今後も複数のリスクが存在することを示唆し続けるだろうが、政策当局者は必要に応じて対応する準備ができていると予測している。 同行は、水曜日の記者会見では、3月の総合インフレ率の上昇とコアインフレ率の鈍化に伴うインフレリスクに関する質問が中心となる可能性が高いと付け加えた。 UBSによると、インフレリスクと、経済活動や労働市場のデータが混在する状況とのバランスも、議論の焦点となる可能性がある。最新の四半期調査でインフレ期待に変化が見られたことを受け、ティフ・マックレム総裁は準備された発言の中で、あるいは質疑応答の中で、インフレ期待の安定が、カナダ銀行がエネルギー価格高騰によるインフレを回避できると考える上で重要な要素であると指摘するかもしれない。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB